ImmunoGen, Inc. Annual Return On Equity in % from 2015 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
ImmunoGen, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2022.
  • ImmunoGen, Inc. Return On Equity for the quarter ending September 30, 2023 was -22.1 %, a 70.9% increase year-over-year.
  • ImmunoGen, Inc. annual Return On Equity for 2022 was -100 %, a 1.62% decline from 2021.
  • ImmunoGen, Inc. annual Return On Equity for 2021 was -98.6 %, a 90% increase from 2020.
  • ImmunoGen, Inc. annual Return On Equity for 2020 was -983 %, a 709% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -100 -1.6 -1.62% Jan 1, 2022 Dec 31, 2022
2021 -98.6 +885 +90% Jan 1, 2021 Dec 31, 2021
2020 -983 -1.14K -709% Jan 1, 2020 Dec 31, 2020
2019 161 +771 Jan 1, 2019 Dec 31, 2019
2018 -610 -692 -846% Jan 1, 2018 Dec 31, 2018
2017 81.7 -75.5 -48% Jan 1, 2017 Dec 31, 2017
2016 157 +262 Jan 1, 2016 Dec 31, 2016
2015 -105 Jul 1, 2014 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.